Home Cart 0 Sign in  

[ CAS No. 1570-05-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1570-05-4
Chemical Structure| 1570-05-4
Structure of 1570-05-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1570-05-4 ]

Related Doc. of [ 1570-05-4 ]

Alternatived Products of [ 1570-05-4 ]

Product Details of [ 1570-05-4 ]

CAS No. :1570-05-4 MDL No. :MFCD01861843
Formula : C21H18O4 Boiling Point : -
Linear Structure Formula :- InChI Key :BYOKJLCIKSFPDU-UHFFFAOYSA-N
M.W : 334.37 Pubchem ID :10854155
Synonyms :

Calculated chemistry of [ 1570-05-4 ]

Physicochemical Properties

Num. heavy atoms : 25
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.1
Num. rotatable bonds : 7
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 95.36
TPSA : 55.76 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.07 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.81
Log Po/w (XLOGP3) : 4.6
Log Po/w (WLOGP) : 4.24
Log Po/w (MLOGP) : 3.66
Log Po/w (SILICOS-IT) : 4.32
Consensus Log Po/w : 3.93

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -4.88
Solubility : 0.00439 mg/ml ; 0.0000131 mol/l
Class : Moderately soluble
Log S (Ali) : -5.5
Solubility : 0.00107 mg/ml ; 0.00000319 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.07
Solubility : 0.0000287 mg/ml ; 0.0000000859 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.5

Safety of [ 1570-05-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1570-05-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1570-05-4 ]
  • Downstream synthetic route of [ 1570-05-4 ]

[ 1570-05-4 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 54544-05-7 ]
  • [ 1570-05-4 ]
YieldReaction ConditionsOperation in experiment
74% With sodium hydroxide; water In methanol for 4 h; Heating / reflux C) 3, 4-Dibenzyloxy benzoic acid; A solution of sodium hydroxide (1.2 g) in methanol (100 ml) was added to a solution of 3,4-dibenzyloxy benzoic acid methyl ester (4.64 g) in methanol (50 ml) and refluxed for 4 hrs. After removal of methanol under reduced pressure the residue was dissolved in water (100 ml) and washed with ethyl acetate (2 x 50 ml). The aqueous layer was acidified with 2N hydrochloric acid to pH 2. The precipitated product was collected by filtration which on drying under vacuum provided 2.4 g of 3,4-benzyloxy benzoic acid. (Yield = 74percent) 'H NMR CDC13 7.7 (2H, b, s) 7.27-7.5 (10H, m) 6.98 (lH, d, J 8Hz) 5.26 (2H, s) 5.22 (2H, s)
32.2 g With sodium hydroxide In tetrahydrofuran; methanol; water at 80℃; for 1 h; To a solution of 8b (15.0 g, 97.4 mmol) in MeOH (360 mL) was added SOCl2 (7.9 mL, 48.7 mmol) fordropwise at 60 °C. The reaction mixture was stirred at 60 °C for 10 h. Then, the reaction mixture wasevaporated under reduced pressure. The crude mixture was applied to following reaction without furtherpurification.To a mixture of crude residue and K2CO3 (40.4 g, 0.292 mol) in DMF (162 mL) was added benzylbromide (29.0 mL, 0.244 mol) at 100 °C. The reaction mixture was stirred at 100 °C for 16 h. Then, thereaction mixture was filtered through a pad of Celite, diluted with H2O, and extracted with EtOAc. Theorganic layer was washed with water and brine, dried over anhydrous MgSO4, and evaporated underreduced pressure. The crude mixture was applied to following reaction without further purification.To a stirred solution of crude residue in MeOH/THF (1/1, 324 mL) were added 4 M NaOH aq. (85 mL,0.34 mol) at 80 °C. The reaction mixture was stirred at same temperature for 1 h. Then, the reactionmixture was quenched with 6 M HCl aq., filtered and washed with H2O to give 9b (32.2 g, 96.3 mmol,99percent) as a white solid.Spectral data for 9b were in good agreement with those reported in reference.16
Reference: [1] Canadian Journal of Chemistry, 2006, vol. 84, # 10, p. 1411 - 1415
[2] Patent: WO2005/113489, 2005, A1, . Location in patent: Page/Page column 90
[3] European Journal of Medicinal Chemistry, 1997, vol. 32, # 5, p. 409 - 423
[4] Heterocycles, 2014, vol. 8, # 2, p. 1371 - 1396
[5] European Journal of Medicinal Chemistry, 2017, vol. 134, p. 24 - 33
  • 2
  • [ 882427-72-7 ]
  • [ 1570-05-4 ]
YieldReaction ConditionsOperation in experiment
2.81 g
Stage #1: With sodium hydroxide In methanol; water at 20℃; Inert atmosphere
Stage #2: With hydrogenchloride In water
General procedure: A solution of hydroxy benzoic acid (1.0 equiv), BnBr (3-5 equiv) and K2CO3 (10-15 equiv) in DMF was stirred overnight under argon. After filtration, the solution was concentrated in vacuo to afford the crude product. The crude product was dissolved in methanol and an aqueous solution of NaOH (75 equiv) was added. The mixture was stirred at room temperature overnight and the solution concentrated in vacuo to remove the methanol. The residue was acidified with 10 percent HCl to pH 2 and then partitioned between ethyl acetate and water. The organic phase was washed with brine, dried (MgSO4 anh), and concentrated. The residue was purified by recrystallization from CH2CH2 / MeOH.
Reference: [1] Synthetic Communications, 2006, vol. 36, # 5, p. 587 - 597
[2] Angewandte Chemie - International Edition, 2010, vol. 49, # 52, p. 10210 - 10213
[3] Inorganic Chemistry, 2010, vol. 49, # 8, p. 3737 - 3745
[4] Journal of Agricultural and Food Chemistry, 2010, vol. 58, # 20, p. 11081 - 11089
[5] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 7, p. 2191 - 2194
[6] European Journal of Medicinal Chemistry, 2011, vol. 46, # 6, p. 2386 - 2396
[7] Patent: CN105596337, 2016, A, . Location in patent: Paragraph 0106; 0107
  • 3
  • [ 99-50-3 ]
  • [ 100-39-0 ]
  • [ 1570-05-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 4, p. 1080 - 1083
[2] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 15, p. 4575 - 4580
[3] Patent: US2015/342984, 2015, A1, . Location in patent: Paragraph 0175
  • 4
  • [ 5447-02-9 ]
  • [ 1570-05-4 ]
Reference: [1] Archiv der Pharmazie, 1997, vol. 330, # 9-10, p. 313 - 316
[2] Bioorganic and Medicinal Chemistry, 1997, vol. 5, # 9, p. 1873 - 1882
[3] Yakugaku Zasshi, 1952, vol. 72, p. 1081,1083[4] Chem.Abstr., 1953, p. 10536
[5] Helvetica Chimica Acta, 1962, vol. 45, p. 270 - 276
[6] Archives of Pharmacal Research, 2011, vol. 34, # 7, p. 1065 - 1070
  • 5
  • [ 99-50-3 ]
  • [ 100-44-7 ]
  • [ 1570-05-4 ]
Reference: [1] Canadian Journal of Biochemistry and Physiology, 1959, vol. 37, p. 1439,1442
[2] Patent: US5498748, 1996, A,
[3] Patent: EP636941, 1995, A1,
  • 6
  • [ 3943-89-3 ]
  • [ 100-39-0 ]
  • [ 584-08-7 ]
  • [ 1570-05-4 ]
YieldReaction ConditionsOperation in experiment
92% With potassium hydroxide In methanol; water; butanone (B)
3,4-DIBENZYLOXYBENZOIC ACID
To 60 g (0.33 mole) of ethyl 3,4-dihydroxybenzoate in 50 ml of methyl ethyl ketone was added 105.5 g (0.76 mole) of K2 CO3 and 168.8 g (0.76 mole) of benzyl bromide.
The mixture was refluxed for 16 hours and filtered.
Evaporation of the filtration gave an oil.
This oil was mixed with 40 g of KOH, 350 ml of water and 350 ml of methanol and refluxed for 2.5 hours.
The methanol was evaporated and the reaction mixture was acidified with concentrated HCl.
The precipitate was filtered to give 101 g (92percent) of the desired product; m.p. 184°-185° C.
The NMR and IR spectra were consistent with the assigned structure.
92% With potassium hydroxide In methanol; water; butanone 3,4-Dibenzyloxybenzoic Acid
To 60 g (0.33 mole) of ethyl 3,4-dihydroxybenzoate in 50 ml of methyl ethyl ketone was added 105.5 g (0.76 mole) of K2 CO3 and 168.8 g (0.76 mole) of benzyl bromide.
The mixture was refluxed for 16 hours and filtered.
Evaporation of the filtration gave an oil.
This oil was mixed with 40 g of KOH, 350 ml of water and 350 ml of methanol and refluxed for 2.5 hours.
The methanol was evaporated and the reaction mixture was acidified with concentrated HCl.
The precipitate was filtered to give 101 g (92percent) of the desired product; m.p. 184°-5° C.
The NMR and IR spectra were consistent with the assigned structure.
92% With potassium hydroxide In methanol; water; butanone (b)
3,4-Dibenzyloxybenzoic Acid
To 60 g (0.33 mole) of ethyl 3,4-dihydroxybenzoate in 50 ml of methyl ethyl ketone was added 105.5 g (0.76 mole) of K2 CO3 and 168.8 g (0.76 mole) of benzyl bromide.
The mixture was refluxed for 16 hours and filtered.
Evaporation of the filtration gave an oil.
This oil was mixed with 40 g of KOH, 350 ml of water and 350 ml of methanol and refluxed for 2.5 hours.
The methanol was evaporated and the reaction mixture was acidified with concentrated HCl.
The precipitate was filtered to give 101 g (92percent) of the desired product; m.p. 184°-185° C.
The NMR and IR spectra were consistent with the assigned structure.
Reference: [1] Patent: US4582855, 1986, A,
[2] Patent: US4402974, 1983, A,
[3] Patent: US4798892, 1989, A,
  • 7
  • [ 13157-90-9 ]
  • [ 13157-89-6 ]
  • [ 1570-05-4 ]
Reference: [1] Tetrahedron, 2000, vol. 56, # 24, p. 4101 - 4106
  • 8
  • [ 2150-43-8 ]
  • [ 1570-05-4 ]
Reference: [1] Canadian Journal of Chemistry, 2006, vol. 84, # 10, p. 1411 - 1415
[2] European Journal of Medicinal Chemistry, 1997, vol. 32, # 5, p. 409 - 423
[3] Heterocycles, 2014, vol. 8, # 2, p. 1371 - 1396
[4] European Journal of Medicinal Chemistry, 2017, vol. 134, p. 24 - 33
  • 9
  • [ 99-50-3 ]
  • [ 1570-05-4 ]
Reference: [1] Canadian Journal of Chemistry, 2006, vol. 84, # 10, p. 1411 - 1415
[2] Synthetic Communications, 2006, vol. 36, # 5, p. 587 - 597
[3] Angewandte Chemie - International Edition, 2010, vol. 49, # 52, p. 10210 - 10213
[4] Journal of Agricultural and Food Chemistry, 2010, vol. 58, # 20, p. 11081 - 11089
[5] European Journal of Medicinal Chemistry, 2011, vol. 46, # 6, p. 2386 - 2396
[6] Patent: CN105596337, 2016, A,
[7] Heterocycles, 2014, vol. 8, # 2, p. 1371 - 1396
  • 10
  • [ 5447-02-9 ]
  • [ 1570-05-4 ]
  • [ 189082-97-1 ]
Reference: [1] European Journal of Medicinal Chemistry, 1999, vol. 34, # 6, p. 539 - 548
  • 11
  • [ 174398-83-5 ]
  • [ 1570-05-4 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 10, p. 3530 - 3537
  • 12
  • [ 3943-89-3 ]
  • [ 1570-05-4 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 10, p. 3530 - 3537
  • 13
  • [ 100-39-0 ]
  • [ 1570-05-4 ]
Reference: [1] Archives of Pharmacal Research, 2011, vol. 34, # 7, p. 1065 - 1070
[2] European Journal of Medicinal Chemistry, 2017, vol. 134, p. 24 - 33
  • 14
  • [ 139-85-5 ]
  • [ 1570-05-4 ]
Reference: [1] Archives of Pharmacal Research, 2011, vol. 34, # 7, p. 1065 - 1070
  • 15
  • [ 58605-10-0 ]
  • [ 1570-05-4 ]
Reference: [1] Yakugaku Zasshi, 1951, vol. 71, p. 1485,1487[2] Chem.Abstr., 1952, p. 7099
  • 16
  • [ 544-16-1 ]
  • [ 17269-65-7 ]
  • [ 141-52-6 ]
  • [ 71-43-2 ]
  • [ 1570-05-4 ]
Reference: [1] Journal of Organic Chemistry, 1940, vol. 5, p. 355,358
  • 17
  • [ 544-16-1 ]
  • [ 27628-06-4 ]
  • [ 141-52-6 ]
  • [ 71-43-2 ]
  • [ 1570-05-4 ]
Reference: [1] Journal of Organic Chemistry, 1940, vol. 5, p. 355,358
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1570-05-4 ]

Aryls

Chemical Structure| 1354549-24-8

[ 1354549-24-8 ]

Methyl 3-methoxy-4-((4-methoxybenzyl)oxy)benzoate

Similarity: 0.98

Chemical Structure| 56441-97-5

[ 56441-97-5 ]

Methyl 4-(benzyloxy)-3-methoxybenzoate

Similarity: 0.98

Chemical Structure| 177429-27-5

[ 177429-27-5 ]

Ethyl 4-(benzyloxy)-3-hydroxybenzoate

Similarity: 0.96

Chemical Structure| 1369851-30-8

[ 1369851-30-8 ]

3,4-Bis(cyclopropylmethoxy)benzoic acid

Similarity: 0.94

Chemical Structure| 1243391-44-7

[ 1243391-44-7 ]

3-(Cyclopropylmethoxy)-4-hydroxybenzoic acid

Similarity: 0.94

Ethers

Chemical Structure| 1354549-24-8

[ 1354549-24-8 ]

Methyl 3-methoxy-4-((4-methoxybenzyl)oxy)benzoate

Similarity: 0.98

Chemical Structure| 56441-97-5

[ 56441-97-5 ]

Methyl 4-(benzyloxy)-3-methoxybenzoate

Similarity: 0.98

Chemical Structure| 177429-27-5

[ 177429-27-5 ]

Ethyl 4-(benzyloxy)-3-hydroxybenzoate

Similarity: 0.96

Chemical Structure| 1369851-30-8

[ 1369851-30-8 ]

3,4-Bis(cyclopropylmethoxy)benzoic acid

Similarity: 0.94

Chemical Structure| 1243391-44-7

[ 1243391-44-7 ]

3-(Cyclopropylmethoxy)-4-hydroxybenzoic acid

Similarity: 0.94

Carboxylic Acids

Chemical Structure| 4442-54-0

[ 4442-54-0 ]

2,3-Dihydro-1,4-benzodioxine-6-carboxylic acid

Similarity: 0.98

Chemical Structure| 1369851-30-8

[ 1369851-30-8 ]

3,4-Bis(cyclopropylmethoxy)benzoic acid

Similarity: 0.94

Chemical Structure| 1243391-44-7

[ 1243391-44-7 ]

3-(Cyclopropylmethoxy)-4-hydroxybenzoic acid

Similarity: 0.94

Chemical Structure| 1486-51-7

[ 1486-51-7 ]

4-(Benzyloxy)benzoic acid

Similarity: 0.94

Chemical Structure| 121-34-6

[ 121-34-6 ]

4-Hydroxy-3-methoxybenzoic acid

Similarity: 0.94